Alnylam Pharmaceuticals | ALNY - 市值

股票价格

301.30

每天变化

-0.81 -0.27%

每月一次

-4.68%

每年

14.46%

Q2 预测

299.00

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 39.15B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	市值	更改		日
Acadia Pharmaceuticals	USD 4.52B		919M	2025-12
Agios Pharmaceuticals	USD 1.53B		57M	2026-04
Alnylam Pharmaceuticals	USD 52.54B		7.24B	2025-12
Amgen	USD 176.25B		24.32B	2025-12
Arrowhead Research	USD 9.02B		4.25B	2025-12
BioCryst Pharmaceuticals	USD 1.66B		64M	2025-12
BioMarin Pharmaceutical	USD 11.42B		1.02B	2025-12
Incyte	USD 21.96B		3.23B	2026-04
Ionis Pharmaceuticals	USD 10.55B		1.91B	2026-04
Neurocrine Biosciences	USD 14.14B		218M	2025-12
Novartis	USD 263.08B		17.01B	2025-12
PTC Therapeutics	USD 5.26B		844M	2026-04
Regeneron Pharmaceuticals	USD 75.46B		6.22B	2026-04
Sanofi	EUR 117.34B		2.45B	2025-12
Sarepta Therapeutics	USD 2.26B		238M	2025-12
Takeda	JPY 7.64T		774.9B	2025-12
Tectonic Therapeutic	USD 390M		96M	2025-12
Ultragenyx Pharmaceutical	USD 2.22B		680M	2025-12
Vertex Pharmaceuticals	USD 115.03B		14.61B	2025-12
Xencor	USD 1.09B		256M	2025-12